ABSTRACT
OBJECTIVE: To identify and validate indicators to improve the assessment of prescribing by primary care paediatricians, incorporating the values and views of the professionals involved. MATERIAL AND METHODS: Nominal group technique, validated through a Delphi survey. PARTICIPANTS: Paediatricians and primary care pharmacists. A nominal group was formed with thirteen specialists. The question raised at the meeting was: "What indicators focusing on the drug and what indicators linked to diagnosis and treatment do you find most helpful in assessing the quality of prescription in paediatrics?", each panellist proposed indicators that were discussed and weighted on a scale from 1 to 9. The highest scored indicators were included in a two round Delphi survey, intended for all paediatricians and primary care pharmacists. MEASUREMENTS: Validity of the indicator; Indicators with a median score equal to or greater than 7 were considered valid. Degree of consensus; it was considered that there was consensus if the interquartile range was not more than 3 points. RESULTS: We generated 29 indicators focusing on the drug and 27 incorporating the diagnosis. Nineteen focusing on the drug and 13 incorporating the diagnosis were included in the survey. There was a high degree of agreement between the group and survey results. CONCLUSIONS: A set of quality indicators for paediatric prescribing has been generated using this tecnique, with consensus of a representative group of stakeholders and validated by all of them.
Subject(s)
Drug Prescriptions/standards , Pediatrics , Primary Health Care , Quality Indicators, Health CareABSTRACT
Objetivo: Seleccionar y validar indicadores que permitan mejorar la evaluación de la prescripción de los pediatras de atención primaria, incorporando los valores y la opinión de los profesionales implicados. Material y métodos: Técnica de grupo nominal, validación mediante encuesta tipo Delphi. Participaron pediatras y farmacéuticos de atención primaria. Se formó un grupo nominal con 13 expertos. En la sesión se planteó la pregunta: "¿Qué indicadores centrados en el fármaco y qué indicadores que relacionen diagnóstico y tratamiento consideras más útiles para evaluar la calidad de la prescripción en pediatría?", cada panelista propuso indicadores que se discutieron y ponderaron en una escala del 1 al 9. Los indicadores más valorados se incluyeron en una encuesta tipo Delphi a dos rondas dirigida a todos los pediatras y farmacéuticos de atención primaria. Las mediciones realizadas fueron: la validez del indicador, se consideraron válidos los indicadores con una mediana de la puntuación igual o superior a 7; el grado de consenso, se consideró que había consenso si el rango intercuartílico no incluía más de 3 puntos. Resultados: Se generaron 29 indicadores centrados en el fármaco y 27 que incorporaban el diagnóstico. Se incluyeron en la encuesta 19 centrados en el fármaco y 13 que incorporaban el diagnóstico. Hubo un alto grado de acuerdo entre el grupo y los resultados de la encuesta. Conclusiones: Mediante esta técnica se ha generando una serie de indicadores de calidad de prescripción para pediatría consensuados por un grupo representativo de los agentes implicados y validado para el conjunto de éstos (AU)
Objective: To identify and validate indicators to improve the assessment of prescribing by primary care paediatricians, incorporating the values and views of the professionals involved. Material and methods: Nominal group technique, validated through a Delphi survey. Participants: Paediatricians and primary care pharmacists. A nominal group was formed with thirteen specialists. The question raised at the meeting was: "What indicators focusing on the drug and what indicators linked to diagnosis and treatment do you find most helpful in assessing the quality of prescription in paediatrics?", each panellist proposed indicators that were discussed and weighted on a scale from 1 to 9. The highest scored indicators were included in a two round Delphi survey, intended for all paediatricians and primary care pharmacists. Measurements: Validity of the indicator; Indicators with a median score equal to or greater than 7 were considered valid. Degree of consensus; it was considered that there was consensus if the interquartile range was not more than 3 points. Results: We generated 29 indicators focusing on the drug and 27 incorporating the diagnosis. Nineteen focusing on the drug and 13 incorporating the diagnosis were included in the survey. There was a high degree of agreement between the group and survey results. Conclusions: A set of quality indicators for paediatric prescribing has been generated using this tecnique, with consensus of a representative group of stakeholders and validated by all of them (AU)
Subject(s)
Humans , Male , Female , Drug Prescriptions/statistics & numerical data , Drug Prescriptions/standards , Indicators of Quality of Life , Primary Health Care/methods , Pediatrics/education , Pediatrics , Pharmacists/organization & administration , Pharmacists , Morbidity Surveys , Health Status Indicators , Quality Indicators, Health Care/statistics & numerical data , Socioeconomic Survey , Pediatrics/statistics & numerical dataABSTRACT
Este trabajo pretende conocer la demanda de información electrónica de los pacientes con infección por VIH y recopilar una lista de direcciones de páginas web con información de calidad sobre el tratamiento dirigida a este grupo de población.Se ha realizado una encuesta sobre el uso de internet entre los pacientes con tratamiento antirretroviral que acuden a la consulta de atención farmacéutica y se han efectuado búsquedas en internet a través de buscadores generales utilizando las palabras clave "SIDA", "tratamiento" y "curación". Los resultados muestran la existencia de un interés por parte de los pacientes con VIH a disponer de información en internet (37 por ciento). La búsqueda ha permitido reunir 16 direcciones con información de calidad, aunque también ha reflejado que circulan por la red electrónica tratamientos para el SIDA sin ninguna base científica.El trabajo pone de manifiesto la necesidad de proporcionar información electrónica fidedigna a los pacientes con VIH que lo precisen, además de orientarles a evaluar la encontrada en la red por su propia cuenta (AU)
